Actively Recruiting
Improve Cancer-related Cognitive Impairment
Led by University of Alabama at Birmingham · Updated on 2025-11-24
64
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.
CONDITIONS
Official Title
Improve Cancer-related Cognitive Impairment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed gynecologic cancer (uterine, cervical, ovarian, primary peritoneal, vulvar, or vaginal) and undergoing chemotherapy
- Own a smartphone or tablet capable of downloading the cognitive training application
- Age over 21 years old
You will not qualify if you...
- Medical diagnosis of dementia
- Taking more than one medication for a significant mental health condition (patients on single-agent therapy for depression or anxiety can participate)
- Age under 21 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Actively Recruiting
Research Team
T
Teresa K Boitano, MD
CONTACT
R
Rebecca Arend, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here